Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia

BACKGROUND: Neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease with dementia (PDD), and dementia with Lewy bodies (DLB) share clinical and molecular features. Cerebrospinal fluid (CSF) biomarkers may help the characterization of these diseases, improving the differenti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Chiasserini, Davide, Biscetti, Leonardo, Eusebi, Paolo, Salvadori, Nicola, Frattini, Giulia, Simoni, Simone, De Roeck, Naomi, Tambasco, Nicola, Stoops, Erik, Vanderstichele, Hugo, Engelborghs, Sebastiaan, Mollenhauer, Brit, Calabresi, Paolo, Parnetti, Lucilla
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5532764/
https://ncbi.nlm.nih.gov/pubmed/28750675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0276-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados